Dietary Supplements

State and local policy issues impacting dietary supplements across the country.

This week, CHPA met with senior staffers on Capitol Hill and other CBD stakeholders to discuss the potential of CBD legislation this Congress, specifically H.R. 841, the Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021.

Join pioneers Patricia Knight, Scott Bass, and Loren Israelsen as they share stories on the founding of DSHEA and why the industry can benefit from its modernization 27 years later.

Prior to the pandemic, the self-care sector was already expanding rapidly, with health spending increasing 31-fold per capita over the past four decades. IRI and CHPA recently released this report about how consumer self-care has specifically changed.

CHPA applauds FDA's inclusion of the publication of a revised version of the New Dietary Ingredient (NDI) Draft Guidance within its priorities for 2022.

The dietary supplements segment has just experienced its largest annual growth rate since 1997. Hear from Dr. Pieter Cohen as he shares his insights on how modernization of DSHEA will help improve category compliance and credibility.

CHPA awarded its Ivan D. Combe Lifetime Achievement Award Wednesday to longtime industry leader Scott Emerson.

The Consumer Healthcare Products Association (CHPA) today announced the election of Michelle Wang Goodridge as the new Chair of the CHPA Board of Directors. Goodridge was elected along with six new board members.

CHPA commends Senators Wyden, Paul, and Merkley for their bipartisan bill which will provide a pathway for CBD to be legally marketed as a dietary supplement.